TETRAPHASE PHARMACEUTICALS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-06-10: Reporting owner Wysenski Nancy; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-06-10: Reporting owner HENWOOD GERALDINE; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-06-10: Reporting owner GAGE L PATRICK; Form 4; Security Stock option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-06-10: Reporting owner Freund John Gordon; Form 4; Security Stock option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-06-10 | Wysenski Nancy Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $0.77 exercise price | 2019-06-11 | |
| 2019-06-10 | HENWOOD GERALDINE Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $0.77 exercise price | 2019-06-11 | |
| 2019-06-10 | GAGE L PATRICK Director | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $0.77 exercise price | 2019-06-11 | |
| 2019-06-10 | Freund John Gordon Director | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $0.77 exercise price | 2019-06-11 | |
| 2019-06-10 | Chodakewitz Jeffrey Director | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $0.77 exercise price | 2019-06-11 | |
| 2019-06-10 | BOHLIN GAREN G Director | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $0.77 exercise price | 2019-06-11 |